TGFβI and S100A4 are abnormally upregulated in HCC, promoting the progression of HCC by activating ferroptosis of HCC cells and inhibiting mitochondrial oxidative stress damage. The gene discussed is TGFBI; the disease is hepatocellular carcinoma.